Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Edgewater Safety Systems, Inc.
With
Rush University Medical Center
After informed consent is obtained and preliminary eligibility established, participants will be trained and issued the Memesto device for use over a 2-week screening/training phase. Participants successfully completing this phase will proceed into a 10-week open label treatment phase (via telephone and/or in-person data collection).
